MJ
Mayuri Jatish Sheth
About Mayuri Jatish Sheth
Data last updated:
Mayuri Jatish Sheth is a Director at Srushti Pharmaceuticals Private Limited (since 2014) and Designated Partner at Meganza Pharma Llp (since 2018). The companies operate in Pharma and Healthcare. The largest current company by reported revenue is Srushti Pharmaceuticals Private Limited at ₹2.26 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Srushti Pharmaceuticals Private Limited U24230KA1985PTC007272 | Director | 12 May 2014 | 1985 | ₹2.26 Cr (FY 2025) | Active |
| Meganza Pharma Llp AAG-8630 | Designated Partner | 31 Mar 2018 | 2016 | Active |
Board colleagues of Mayuri Jatish Sheth
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jatish Sheth | 00581963 | Srushti Pharmaceuticals Private Limited , Meganza Pharma Llp | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mayuri Jatish Sheth
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mayuri Jatish Sheth
Mayuri Jatish Sheth currently holds 2 directorships: Srushti Pharmaceuticals Private Limited (Director, since 12 May 2014, revenue ₹2.26 Cr (FY 2025)); Meganza Pharma Llp (Designated Partner, since 31 Mar 2018).
Mayuri Jatish Sheth was first appointed on 12 May 2014 as Director at Srushti Pharmaceuticals Private Limited. The most recent appointment on record is 31 Mar 2018 at Meganza Pharma Llp.
The current boards of Mayuri Jatish Sheth's companies include Jatish Sheth (Srushti Pharmaceuticals Private Limited).